<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>13</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2021</Year>
        <Month>04</Month>
        <Day>10</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Antibiotics susceptibility of Escherichia coli isolates from clinical specimens before and during COVID-19 pandemic</title>
    <FirstPage>156</FirstPage>
    <LastPage>160</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Eustachius</FirstName>
        <LastName>Wardoyo</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Universitas Mataram, Mataram, Indonesia; Department of Doctoral Studies, School of Medicine, Universitas Udayana, Bali, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>I Wayan</FirstName>
        <LastName>Suardana</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Veterinary Medicine, Universitas Udayana, Bali, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>I Wayan Putu</FirstName>
        <LastName>Yasa</LastName>
        <affiliation locale="en_US">Department of Clinical Pathology, School of Medicine, Universitas Udayana, Bali, Indonesia</affiliation>
      </Author>
      <Author>
        <FirstName>I Dewa</FirstName>
        <LastName>Sukrama</LastName>
        <affiliation locale="en_US">Department of Microbiology, School of Medicine, Universitas Udayana, Bali, Indonesia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>11</Month>
        <Day>09</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>03</Month>
        <Day>20</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Escherichia coli is a Gram-negative organism causing mild to severe infections, with a wide spectrum range of organs involved. The study aimed to describe antibiotics susceptibility of E. coli from clinical specimens from October 11, 2019 to September 11, 2020.
Materials and Methods: Study was conducted retrospectively in a private microbiology laboratory in Mataram Indonesia. Period of study divided as two groups after WHO declared COVID-19 as pandemic by March 11, 2020; group A including the specimen related to September 2019 to March 11th 2020 and group B including the specimens related to March 11th 2020 to September 2020. All clinical specimens were subjected to identify E. coli isolates and their antibiotics susceptibility using WHO-NET 5.6 version.
Results: Totally, 148 E. coli isolates were found in group A and 62 isolates in group B. Prevalence of extended-spectrum beta lactamase (ESBL)- producing E. coli in group A was 50% and in group B was 20.9% with significantly difference (p&lt;0.05). There was an increase in susceptibility to 10/16 antibiotics; where 3 antibiotics ofloxacin, aztreonam, and fosfomycin were significant (p&lt;0.05). There was a significant decrease in susceptibility to the antibiotics piperacillin (p=0.012), amoxicillin (p=0.002), cefadroxil (p=0.036) and ampicillin (p=0.036). Type of infections between two groups: musculoskeletal infections, pneumonia, urinary tract infections and sepsis were not significant.
Conclusion: Reduced number of E. coli isolates between two groups with decrease of ESBL-producing E. coli contribute in dynamics of antibiotics susceptibility. The longer period of analysis is needed to be done, due to the ongoing COVID-19 pandemic.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/2848</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/2848/1328</pdf_url>
  </Article>
</Articles>
